Lethal infection of Lassa virus isolated from a human clinical sample in outbred guinea pigs without adaptation

Junki Maruyama, John T. Manning, Elizabeth J. Mateer, Rachel Sattler, Natalya Bukreyeva, Cheng Huang, Slobodan Paessler

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Lassa virus (LASV), a member of the family Arenaviridae, is the causative agent of Lassa fever. Lassa virus is endemic in West African countries, such as Nigeria, Guinea, Liberia, and Sierra Leone, and causes outbreaks annually. Lassa fever onset begins with "flu-like" symptoms and may develop into lethal hemorrhagic disease in severe cases. Although Lassa virus is one of the most alarming pathogens from a public health perspective, there are few licensed vaccines or therapeutics against Lassa fever. The fact that animal models are limited and the fact that mostly laboratory-derived viruses are used for studies limit the successful development of countermeasures. In this study, we demonstrated that the LASV isolate LF2384-NSDIA- 1 (LF2384), which was directly isolated from a serum sample from a fatal human Lassa fever case in the 2012 Sierra Leone outbreak, causes uniformly lethal infection in outbred Hartley guinea pigs without virus-host adaptation. This is the first report of a clinically isolated strain of LASV causing lethal infection in outbred guinea pigs. This novel guinea pig model of Lassa fever may contribute to Lassa fever research and the development of vaccines and therapeutics.

Original languageEnglish (US)
Article numbere00428-19
JournalmSphere
Volume4
Issue number5
DOIs
StatePublished - Jan 1 2019

Fingerprint

Lassa Fever
Lassa virus
Guinea Pigs
Infection
Sierra Leone
Disease Outbreaks
Arenaviridae
Vaccines
Liberia
Guinea
Viruses
Nigeria
Animal Models
Public Health
Therapeutics
Serum
Research

Keywords

  • Animal model
  • Clinical isolate
  • Guinea pig
  • Lassa virus

ASJC Scopus subject areas

  • Microbiology
  • Molecular Biology

Cite this

Lethal infection of Lassa virus isolated from a human clinical sample in outbred guinea pigs without adaptation. / Maruyama, Junki; Manning, John T.; Mateer, Elizabeth J.; Sattler, Rachel; Bukreyeva, Natalya; Huang, Cheng; Paessler, Slobodan.

In: mSphere, Vol. 4, No. 5, e00428-19, 01.01.2019.

Research output: Contribution to journalArticle

@article{dffe4728b8b941df829fc21662726b51,
title = "Lethal infection of Lassa virus isolated from a human clinical sample in outbred guinea pigs without adaptation",
abstract = "Lassa virus (LASV), a member of the family Arenaviridae, is the causative agent of Lassa fever. Lassa virus is endemic in West African countries, such as Nigeria, Guinea, Liberia, and Sierra Leone, and causes outbreaks annually. Lassa fever onset begins with {"}flu-like{"} symptoms and may develop into lethal hemorrhagic disease in severe cases. Although Lassa virus is one of the most alarming pathogens from a public health perspective, there are few licensed vaccines or therapeutics against Lassa fever. The fact that animal models are limited and the fact that mostly laboratory-derived viruses are used for studies limit the successful development of countermeasures. In this study, we demonstrated that the LASV isolate LF2384-NSDIA- 1 (LF2384), which was directly isolated from a serum sample from a fatal human Lassa fever case in the 2012 Sierra Leone outbreak, causes uniformly lethal infection in outbred Hartley guinea pigs without virus-host adaptation. This is the first report of a clinically isolated strain of LASV causing lethal infection in outbred guinea pigs. This novel guinea pig model of Lassa fever may contribute to Lassa fever research and the development of vaccines and therapeutics.",
keywords = "Animal model, Clinical isolate, Guinea pig, Lassa virus",
author = "Junki Maruyama and Manning, {John T.} and Mateer, {Elizabeth J.} and Rachel Sattler and Natalya Bukreyeva and Cheng Huang and Slobodan Paessler",
year = "2019",
month = "1",
day = "1",
doi = "10.1128/mSphere.00428-19",
language = "English (US)",
volume = "4",
journal = "mSphere",
issn = "2379-5042",
publisher = "American Society for Microbiology",
number = "5",

}

TY - JOUR

T1 - Lethal infection of Lassa virus isolated from a human clinical sample in outbred guinea pigs without adaptation

AU - Maruyama, Junki

AU - Manning, John T.

AU - Mateer, Elizabeth J.

AU - Sattler, Rachel

AU - Bukreyeva, Natalya

AU - Huang, Cheng

AU - Paessler, Slobodan

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Lassa virus (LASV), a member of the family Arenaviridae, is the causative agent of Lassa fever. Lassa virus is endemic in West African countries, such as Nigeria, Guinea, Liberia, and Sierra Leone, and causes outbreaks annually. Lassa fever onset begins with "flu-like" symptoms and may develop into lethal hemorrhagic disease in severe cases. Although Lassa virus is one of the most alarming pathogens from a public health perspective, there are few licensed vaccines or therapeutics against Lassa fever. The fact that animal models are limited and the fact that mostly laboratory-derived viruses are used for studies limit the successful development of countermeasures. In this study, we demonstrated that the LASV isolate LF2384-NSDIA- 1 (LF2384), which was directly isolated from a serum sample from a fatal human Lassa fever case in the 2012 Sierra Leone outbreak, causes uniformly lethal infection in outbred Hartley guinea pigs without virus-host adaptation. This is the first report of a clinically isolated strain of LASV causing lethal infection in outbred guinea pigs. This novel guinea pig model of Lassa fever may contribute to Lassa fever research and the development of vaccines and therapeutics.

AB - Lassa virus (LASV), a member of the family Arenaviridae, is the causative agent of Lassa fever. Lassa virus is endemic in West African countries, such as Nigeria, Guinea, Liberia, and Sierra Leone, and causes outbreaks annually. Lassa fever onset begins with "flu-like" symptoms and may develop into lethal hemorrhagic disease in severe cases. Although Lassa virus is one of the most alarming pathogens from a public health perspective, there are few licensed vaccines or therapeutics against Lassa fever. The fact that animal models are limited and the fact that mostly laboratory-derived viruses are used for studies limit the successful development of countermeasures. In this study, we demonstrated that the LASV isolate LF2384-NSDIA- 1 (LF2384), which was directly isolated from a serum sample from a fatal human Lassa fever case in the 2012 Sierra Leone outbreak, causes uniformly lethal infection in outbred Hartley guinea pigs without virus-host adaptation. This is the first report of a clinically isolated strain of LASV causing lethal infection in outbred guinea pigs. This novel guinea pig model of Lassa fever may contribute to Lassa fever research and the development of vaccines and therapeutics.

KW - Animal model

KW - Clinical isolate

KW - Guinea pig

KW - Lassa virus

UR - http://www.scopus.com/inward/record.url?scp=85072562678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072562678&partnerID=8YFLogxK

U2 - 10.1128/mSphere.00428-19

DO - 10.1128/mSphere.00428-19

M3 - Article

C2 - 31554720

AN - SCOPUS:85072562678

VL - 4

JO - mSphere

JF - mSphere

SN - 2379-5042

IS - 5

M1 - e00428-19

ER -